Wisteria - Wee inhibitor with Cisplatin and Radiotherapy: A trial in head and neck cancer

Kong, Anthony (Co-Investigator)
Mehanna, Hisham (Principal Investigator)
Parish, Jo (Co-Investigator)
Windridge, Dave (Co-Investigator)

Short title	Wisteria - Wee inhibitor with Cisplatin and Radiotherapy: A trial in head and neck cancer
Status	Active
Effective start/end date	1/09/15 → 31/12/24

Funding

Cancer Research Uk
ASTRA ZENECA UK LIMITED

2 Article

Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer
Kong, A., Kirkham, A. J., Savage, J. S., Mant, R., Lax, S., Good, J., Forster, M. D., Sacco, J. J., Schipani, S., Harrington, K. J., Yap, C. & Mehanna, H., 29 Jan 2024, In: BJC Reports. 2, 1, 9 p., 6.
Research output: Contribution to journal › Article › peer-review

Open Access
File
18 Downloads (Pure)
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol
Kong, A., Good, J. S., Kirkham, A., Savage, J., Mant, R., Llewellyn, L., Parish, J., Spruce, R., Forster, M., Schipani, S., Harrington, K., Sacco, J. J., Murray, P., Middleton, G., Yap, C. & Mehanna, H., 16 Mar 2020, In: BMJ open. 10, 3, 11 p., e033009.
Research output: Contribution to journal › Article › peer-review

Open Access
File
6 Citations (Scopus)

161 Downloads (Pure)